Return to search results
Abacavir
Abacavir is a prescription antiviral medication used to treat HIV infection by inhibiting the virus's ability to replicate. It comes as an oral tablet with 300 mg of abacavir sulfate, manufactured by Camber Pharmaceuticals, Inc. Always consult a healthcare provider for proper use. This information was generated using AI and is provided for informational and research purposes only.
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| accrualPeriodicity | R/P1Y |
| bureauCode |
[
"009:10"
]
|
| contactPoint |
{
"fn": "Division of Drug Information",
"@type": "vcard:Contact",
"hasEmail": "mailto:druginfo@fda.hhs.gov"
}
|
| description | Abacavir is a prescription antiviral medication used to treat HIV infection by inhibiting the virus's ability to replicate. It comes as an oral tablet with 300 mg of abacavir sulfate, manufactured by Camber Pharmaceuticals, Inc. Always consult a healthcare provider for proper use. This information was generated using AI and is provided for informational and research purposes only. |
| distribution |
[
{
"@type": "dcat:Distribution",
"title": "Abacavir",
"mediaType": "text/html",
"description": "
Access the FDA dataset for Abacavir — ANDA 205551 submitted by Mylan Institutional LLC
",
"downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205551"
}
]
|
| identifier | ANDA205551 |
| issued | 2016-09-16 |
| keyword |
[
"drug",
"drug-manufacturers",
"health-care",
"medications",
"pharmaceuticals"
]
|
| landingPage | https://www.fda.gov/drugs |
| license | https://open.fda.gov/license |
| modified | 2025-03-17 |
| programCode |
[
"009:002"
]
|
| publisher |
{
"name": "U.S. Food and Drug Administration",
"@type": "org:Organization"
}
|
| theme |
[
"FDA"
]
|
| title | Abacavir |
